Polyrizon Stock (NASDAQ:PLRZ)
Previous Close
$1.39
52W Range
$0.55 - $1.20K
50D Avg
$1.01
200D Avg
$179.03
Market Cap
$9.06M
Avg Vol (3M)
$8.02M
Beta
-5.93
Div Yield
-
PLRZ Company Profile
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.